Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need ...

HCW Biologics gets US FDA nod to begin first-in-human phase 1 trial of HCW9302 to treat patients with moderate-to-severe alopecia areata: Miramar, Florida Wednesday, February 5, 2 ...

Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...

Mallia Therapeutics & Northway Biotech partner to manufacture soluble CD83 protein for hair loss treatment: Erlangen, Germany Wednesday, February 5, 2025, 15:00 Hrs [IST] Mallia T ...

Mallia Therapeutics and Northway Biotech Announce Partnership for the Manufacturing of Soluble CD83 Protein for Hair Loss Treatment With Northway ...

Leading measurement and analytics company Adjust released today its annual Mobile App Trends report for 2025, showing strong momentum following the app economy's 2022 dip. Global app installs ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...